Damien; et al. (2019): Real-Time in situ Observations Reveal a Double Role for Ascorbic Acid in the Anisotropic Growth of Silver on Gold. ChemRxiv. Preprint.Rational nanoparticle design is one of the main goals of materials science, but it can only be achieved via a thorough understanding of the growth process and of the respective roles of the molecular species involved.We demonstrate that a combination of complementary techniques can yield novel information with respect to their individual contributions. We monitored the growth of long aspect ratio silver rods from gold pentatwinned seeds by three in situ techniques (small-angle x-ray scattering, optical absorbance spectroscopy and liquid-cell transmission electron microscopy). Exploiting the difference in reaction speed between the bulk synthesis and the nanoparticle formation in the TEM cell, we show that the anisotropic growth is thermodynamically controlled (rather than kinetically) and that ascorbic acid, widely used for its mild reductive properties plays a shape-directing role, by stabilizing the {100} facets of the silver cubic lattice, in synergy with the halide ions. This approach can easily be applied to a wide variety of synthesis strategies. File list (5) download file view on ChemRxiv AuAg in situ.pdf (794.37 KiB) download file view on ChemRxiv Supplementary_Information.pdf (2.72 MiB) download file view on ChemRxiv Video_1.mp4 (3.11 MiB) download file view on ChemRxiv Video_2.mp4 (2.97 MiB) download file view on ChemRxiv Video_3.mp4 (2.18 MiB)Real-time in situ observations reveal a double role for ascorbic acid in the anisotropic growth of silver on gold
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.